Ramon Zegpi Lagos, DVM, PhD, discusses H5N1 (avian flu), risks, transmission dynamics, preventive measures, and ongoing research at The Ohio State University.
Cows have been found to be infected with H5N1.
(Adobe Stock 10402324 by AF)
Highly pathogenic avian Influenza (HPAI) A(H5N1) viruses outbreaks have been widespread in wild birds and sporadic in poultry flocks and mammals, including bobcats, striped skunks, raccoons, mountain lions, squirrels, polar and black bears, red foxes, and harbor seals.1 To complicate the situation, the virus has been found in 2 humans in the US, 1 in Texas and 1 in Colorado.2
The CDC says these infections do not “change the H5N1 bird flu human health risk assessment for the US general public, which CDC considers to be low. However, people with close or prolonged, unprotected exposures to infected birds or other animals (including livestock) or environments contaminated by infected birds or other animals are at greater risk of infection. CDC has interim recommendations for prevention, monitoring, and public health investigations of HPAI A(H5N1) viruses.”2
It has been reported that the latest case of infection was exposed to dairy cattle in Texas, which are believed to be infected with HPAI A(H5N1) viruses. The infected person experienced only one symptom ie, conjunctivitis, which caused redness in their eyes. However, the patient is recovering well and is currently being treated with an antiviral drug for influenza. They were instructed to isolate themselves to avoid spreading the disease.2
Other states also have had outbreaks: Idaho, South Dakota, Kansas, New Mexico, North Carolina, Michigan, and Ohio.3
To get more clarity on how concerned health care workers and those who work with cattle3 should be, Infection Control Today® (ICT®) asked Ramon Zegpi Lagos, DVM, PhD, assistant professor and poultry disease specialist at The Ohio State University, Wooster, Ohio. Zegpi Lagos is an expert in poultry diseases, pathogen-host interactions, immune responses in chickens, and vaccine development.
“As you know, one person was confirmed to be affected by HPAI H5N1,”3 Zegpi Lagos said. “This person was exposed to dairy cattle that were confirmed to be infected with H5N1 HPAI. HPAI has crossed the species barrier plenty of times already, infecting multiple wild bird and mammal species. Furthermore, there is no evidence of person-to-person transmission of the avian influenza case in Texas. Lastly, the genomic sequence of the H5N1 found in cattle shows minor changes compared to the original avian H5N1, with little to no adaptation to mammal hosts. All this evidence supports the decision of the CDC to not change the H5N1 bird flu human health risk assessment for the US, which CDC considers low at the moment.”
Zegpi Lagos explains how the virus may present in cattle. “The method of transmission between cattle is not clear. HPAI has an initial respiratory tract tropism, and then, after a viremia, the virus can reach other organs in birds. In cattle, however, the respiratory tract does not play a primary role in virus spread. Scientists believe the transmission route is related to the mammary gland and contaminated milk production equipment.”
Then Zegpi Lago clarified, “As a side note, pasteurized milk should not pose any risk for HPAI transmission since the virus does not resist high temperatures.”
Continuing research
Research continues despite possible challenges, Zegpi Lagos assured ICT. “At OSU, we have facilities that could host animals and the virus for research, but many requirements need to be met before starting research in BSL3 (Biosafety Level 3*) facilities that contain infectious agents or toxins that can be transmitted through the air and cause potentially lethal infections) conditions. We don’t know yet if the HPAI H5N1 will be considered a select agent; if so, it will make working with it harder for research. Evaluating the cross-species transmission from cows to other animals, understanding the transmission dynamics in cows, and understanding the tropism of the virus in cattle are some questions that need answers.”
* (Facilities designated Biosafety Level 3 are those that contain infectious agents or toxins that can be transmitted through the air and cause possibly fatal infections)
Reducing infection Risk
The CDC suggests minimizing the infection risk when around birds, cattle, or other possibly infected animals; individuals should adhere to several preventive measures.3 Firstly, avoiding direct contact with sick or deceased animals, including wild birds, poultry, and other domesticated animals, including cows, is crucial. If you do touch a sick animal, wash your hands well with soap and warm water. Additionally, steering clear of unprotected exposure to animal feces, bedding, or raw milk, especially from birds or animals suspected of harboring the H5N1 bird flu virus, is essential.
Consuming uncooked or undercooked food products, such as raw milk or cheeses, should also be avoided from animals with suspected or confirmed H5N1 bird flu virus infection. Fortunately, commercially available milk is safe for consumption as it undergoes pasteurization, effectively eliminating bacteria and viruses like influenza.
Similarly, properly handled and cooked poultry in the US proposes no risk, provided it reaches an internal temperature of 165˚F, effectively killing bacteria and viruses, including bird flu viruses.
References
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.